32 results
8-K
EX-1.1
COCP
Cocrystal Pharma Inc
5 May 21
Entry into a Material Definitive Agreement
5:02pm
, exhibits and schedules. Notwithstanding anything herein to the contrary, the Engagement Agreement, dated May 4, 2021 (“Engagement Agreement … that, in the event of a conflict between the terms of the Engagement Agreement and this Agreement, the terms of this Agreement shall prevail.
7.3 Notices
424B5
COCP
Cocrystal Pharma Inc
5 May 21
Prospectus supplement for primary offering
4:01pm
of our engagement of the underwriter, we shall pay the underwriter the cash compensation provided above on the gross proceeds from such investors
8-K
EX-1.1
COCP
Cocrystal Pharma Inc
27 Aug 20
Entry into a Material Definitive Agreement
5:25pm
, the Engagement Agreement, dated August 19, 2020 (“Engagement Agreement”), by and between the Company and the Representative, shall continue … and be enforceable by the Representative in accordance with its terms, provided that, in the event of a conflict between the terms of the Engagement
424B5
2ndwff5axpjmzp
27 Aug 20
Prospectus supplement for primary offering
5:24pm
424B5
obkk7kb9g8
26 Aug 20
Prospectus supplement for primary offering
5:30pm
8-K
EX-1.1
a0ken6pb5hdj
2 Jul 20
Entry into a Material Definitive Agreement
9:30am
8-K
4daa8u
13 Mar 20
Cocrystal Pharma Announces Closing of $6.8 Million Registered Direct Offering Priced At-the-Market
4:44pm
8-K
EX-10.2
t9li 52tz
4 Mar 20
Cocrystal Pharma Announces Closing of $11.0 Million Registered Direct Offering Priced At-the-Market
5:09pm
8-K
b60et 4svn
4 Mar 20
Cocrystal Pharma Announces Closing of $11.0 Million Registered Direct Offering Priced At-the-Market
5:09pm
8-K
EX-1.1
cm2wpk
31 Jan 20
Entry into a Material Definitive Agreement
8:01am
8-K
EX-1.1
426sd
31 Oct 19
Entry into a Material Definitive Agreement
9:29am
8-K
bawqa
18 Apr 19
Changes in Registrant's Certifying Accountant
4:26pm